Aehr Test Systems
This is the archived full research. Read the story
A small California maker of machines that heat and power chips for hours so the weak ones fail in the factory, now selling mostly to AI chip makers.
The scores
Growth2/4 ↑
Revenue fell two years to $50.0M, then rose 200% to a record $33.0M in one quarter; one quarter is not yet an engine.
Business quality3/4 ↑
The only supplier shown doing wafer-level AI burn-in, but on one unnamed customer, with rivals in silicon carbide and package level.
Financial position3/4 ↑
Net cash of $105.1M and no debt, raised from share sales rather than operations, which used $3.1M in the quarter.
Execution record2/4 ↑
The fiscal 2024 guide fell from $100M to $66M in two cuts; fiscal 2026's was met, one clean year since.
Per share capture3/4 →
Shares up about 17% in four years with flat revenue, but the recent sales were made at high prices and nothing ranks ahead.
Potential2/4 ↑
A large AI market, but growth past fiscal 2027 needs customers who have not ordered, and the burn-in slice is unmeasured.
Risk profile2/4 →
Three customers were half of revenue, and the guide rests on two unnamed buyers' cancellable orders.
Valuation1/4 ↑
About 23.5 times sales, 573% of a three-stage value near $9.20 at an 8% return: priced for perfection, beyond the 20% margin.
Evidence quality3/4 →
Revenue, cash and insider sales are filed; customers, the AI share and every order since May are management's own.
If it works 0.6× · if it fails you keep up to 5%.
The Verdict
We rate Aehr Test Systems Unattractive. It is the one company shown screening AI chips while still on the wafer, with orders covering nearly all of this year's forecast, but sales fell two years running before this, a few unnamed buyers carry it and rivals offer the same test for finished chips, so the business is mixed. The price sits far above our value and our best case, while the production order we wait for has not come. As a bet it is fragile: if the AI orders stop, shareholders keep little beyond the cash.
The long caseIf AI chips keep packing more dies and memory into one package, screening each die before packaging pays, and Aehr is the one shown doing it.
How we weighed it
The price against our value
Against it
Price at 582% of our value
The price sits far above our value and above the bull case.
The business
Cuts both ways
Mixed
A mixed business: a unique tool, with sales that fell for two years.
Growth against what the price assumes
In its favour
Orders cover nearly all of this year's raised forecast.
What could go wrong
Against it
A few buyers carry it, rivals offer burn-in for finished chips and margins are under pressure.
Against competitors
Cuts both ways
No filed rival compares directly; the rise came from the price, not sales per share.
How its group is behaving
Cuts both ways
Chip-equipment names move together on news about chipmakers' spending.
The latest news and report
In its favour
The last report raised the forecast and recovered the margin.
The evidence under this - 6 claims
The customer is unnamed, and EDGAR full-text search finds no filing by onsemi, Intel, TSMC or NVIDIA naming Aehr (S01).
Bookings and effective backlog are the company's own measures; the filed backlog at the year end was $80.6M and cancellable (C07).
- 2026-11-03editedQ1 fiscal 2027 release: bookings of $46.7M exceeded revenue by over 40% and effective backlog rose to $109.3M after $33.0M was shipped.
The vendor put company value at $3.26B on an older share count, 63.9 times trailing sales at the October 5 close (S11); the share count here is still July's, and the first-quarter 10-Q will give the current one.
- 2026-10-23editedre-struck at the 22 October close of $55.65, 46.7% below the 5 October close it was struck at
- 2026-11-03editedRe-struck at the 2 November close of $51.47 (from $55.65) with September's cash of $105.1M and the raised $150M guide; the share count is still July's, the 10-Q not yet being filed.
The company
Some chips are weak from birth and fail in their first weeks of use. Burn-in finds them by running chips hot and under power for hours in the factory.
Aehr's main machine does this to whole wafers, the discs chips are cut from, nine at once, through a contact plate built for each chip design. A second line, bought in 2024, handles finished chips.
Its biggest AI customer used to test chips after packaging and now does all its burn-in on the wafer instead.
The evidence under this - 4 claims
The customer is unnamed, and EDGAR full-text search finds no filing by onsemi, Intel, TSMC or NVIDIA naming Aehr (S01).
How it makes money
Aehr earns most of its money selling the machines: $28.7M of last year's $50.0M. The contact plates made for each chip design brought in $14.9M, and are bought again whenever a customer changes its chip, so management treats them as repeat business. Service brought the rest.
The money comes from very few hands: five customers paid 70% of last year's sales, and none is named.
The evidence under this - 3 claims
Contactors were $14.9M of $50.0M, 30%, in fiscal 2026 (C03), which agrees; the 40% is not in the 10-K.
Where the money comes from, stream by stream
| Stream | Share of sales (FY2026) | How it earns it |
|---|---|---|
| Systems | 57.4% | FOX-XP, FOX-NP and Sonoma burn-in systems, booked on shipment or acceptance. |
| WaferPak and DiePak contactors | 29.8% | Custom contactors made for each chip design, bought again as designs change; management calls them consumables. |
| Services | 12.8% | Installation, support and spare parts on installed systems. |
Who runs it
Gayn Erickson has run Aehr since 2012, through the car-chip boom and the turn to AI. The founder, Rhea Posedel, is still chairman.
Insiders own about 4.6%. Bonuses paid nothing last year, and long-term share awards pay on reaching a sales target by June 2027. Insiders sold 743,893 shares in the past year, none under a pre-set selling plan, and bought none.
The evidence under this - 4 claims
Why it wins, and who could beat it
Why customers come back
An AI chip is now packaged with several other chips and stacks of memory, so one weak chip can spoil an expensive package. Intel has said many defects still get past the wafer stage. Aehr says catching them earlier pays many times over, though that figure is its own.
Its edge is know-how in powering a whole wafer at once, kept mostly secret. Nobody else is shown doing it for AI chips; for car chips, a Chinese rival sells a similar machine and won the first patent ruling.
The evidence under this - 5 claims
No buyer has published what a failed AI package costs it; Intel says defects still escape wafer test to package test but puts no figure on it (S22).
The threat
The main alternative is to test after packaging, as Teradyne's and Advantest's machines do; Aehr's lead AI customer stopped doing that. For finished AI chips, rivals such as AEM in Singapore already sell burn-in machines, and AEM says a large AI chip designer chose it. For car chips, three Asian makers sell wafer machines like Aehr's.
The evidence under this - 3 claims
The rivals: TER, TRT, and 3 more that are private, in-house or listed abroad.
Who else does this, rival by rival
| Ticker | Rival | Where it competes | How far along | Priced against it |
|---|---|---|---|---|
| TER | System-level test after packaging, from Teradyne and AdvantestPriced against it: Different product | Wafer-level burn-in | On sale | Different product |
| Private | Semight and Nexustest nine-wafer burn-in systemsPriced against it: Private | Wafer-level burn-in | On sale | Private |
| AEM's automated burn-in for AI processorsPriced against it: Listed abroad | Package-level burn-in | On sale | Listed abroad | |
| TRT | Trio-Tech's burn-in boards and systemsPriced against it: Same product | Package-level burn-in | On sale | Same product |
| Pentamaster's Trooper-BI wafer-level burn-inPriced against it: Listed abroad | Wafer-level burn-in | On sale | Listed abroad |
How big it could get
How big this could get
Chip-testing machines of all kinds sell for about $15.3B a year, on the industry group SEMI's forecast for 2026, rising to $20.8B by 2028. Aehr sold $50.0M last year.
Nobody outside the company measures how much of that is burn-in, so the true size of Aehr's market is unknown. What is measured is the driver: TSMC, which makes most AI chips, expects its AI chip sales to grow by well over half a year until 2029.
The evidence under this - 3 claims
SEMI's 2025 figure moved from $11.2B to about $11.7B in seven months, and it counts all test equipment, not burn-in (S18, S19).
TSMC is a supplier with a stake in the AI story; the growth rate is its forecast, not its customers' orders.
SEMI does not split out burn-in, so no outside measure confirms it (S19).
Who has signed
Since May the lead AI customer ordered $22M of wafer machines, a large internet company $41M of the finished-chip machines, and a light-chip customer two more systems. Car-chip customers added more than $8M.
None of these buyers is named, and the company says most orders can be cancelled with small penalties.
The evidence under this - 5 claims
The customer is unnamed, and EDGAR full-text search finds no filing by onsemi, Intel, TSMC or NVIDIA naming Aehr (S01).
The customer is unnamed and no customer filing names Aehr (S01).
- 2026-11-03editedQ1 fiscal 2027 call: more than a dozen Sonoma systems a month, second processor qualified with follow-on orders; all still management's account of an unnamed customer.
- 2026-11-03editedQ1 fiscal 2027 release: backlog $100.9M at September 25; the cancellation terms are the 10-K's, and the quarter's 10-Q is not yet filed.
The results
The numbers
Sales grew 27% over the twelve months to Sep 2026, faster than the −15% in the year to May 2026.
Operating margin is −5.6%, down from 15% in the year to May 2024.
Running costs take 47¢ of each sales dollar, up from 31¢ in the year to May 2022.
Shareholders' money earned 1.0% a year, down from 30% in the year to May 2022.
It used $6.81M of cash over the last twelve months, so the $105M it holds lasts about 15.4 years at that pace.
Yearly sales growth has ranged from −15% to +206% over the last 5 years, with sales falling in 2 of them.
The share count rose 21% in 4.3 years, and pay in shares costs 9.7% of sales.
All the numbers
Filed figures from the company's 10-K and 10-Q, read 2026-11-10. Fiscal years end in May.
| May 2022 | May 2023 | May 2024 | May 2025 | May 2026 | 12 mo to Sep 2026 | |
|---|---|---|---|---|---|---|
| Size and growth | ||||||
| Sales | $50.8M | $65.0M | $66.2M | $59.0M | $50.0M | $72.0M |
| Sales growth | +206% | +28% | +1.9% | −11% | −15% | +27% |
| Profit | ||||||
| Gross margin | 47% | 50% | 49% | 41% | 35% | 41% |
| Operating margin | 15% | 21% | 15% | −9.6% | −28% | −5.6% |
| Net margin | 19% | 22% | 50% | −6.6% | −14% | 3.0% |
| What growth costs, per sales dollar | ||||||
| Research and development | 11% | 11% | 13% | 18% | 25% | 19% |
| Selling, general and admin | 20% | 19% | 21% | 31% | 38% | 28% |
| Pay in shares | 5.9% | 4.2% | 3.8% | 8.8% | 14% | 9.7% |
| Capital spending | 0.8% | 2.1% | 1.1% | 8.5% | 4.1% | 1.0% |
| Cash | ||||||
| Cash from operations | $1.51M | $10.0M | $1.76M | −$7.40M | −$3.31M | −$6.08M |
| Free cash flow | $1.09M | $8.65M | $1.01M | −$12.4M | −$5.38M | −$6.81M |
| Balance sheet | ||||||
| Cash and short-term investments | $31.5M | $47.9M | $49.2M | $24.5M | $116M | $105M |
| Debt | $0 | - | - | - | - | - |
| Net cash | $31.5M | - | - | - | - | - |
| Returns and shares | ||||||
| Return on capital | 24% | 21% | 11% | - | - | - |
| Shares (diluted) | 27.8M | 29.2M | 29.6M | 29.6M | 30.7M | 33.5M |
What growth costs
Aehr has been spending ahead of its sales. Research, selling and office costs took 31 cents of each sales dollar in fiscal 2022 and 64 cents last year, on the same sales. The profit forecast needs sales to rise much faster than those costs.
The evidence under this - 2 claims
The company guided fiscal 2024 to at least $100M in July 2023 and delivered $66.2M (C14).
- 2026-11-03editedQ1 fiscal 2027 release: guide raised from $130M-$150M to $150M, not cut; non-GAAP net income target at least 20% of revenue.
The last report (2 Nov)
Quarter ended September 2026, filed figures.
In the quarter to 25 September 2026, Aehr's sales rose 200% to a record $33.0M and it made $7.2M. The share of each dollar kept after production costs recovered to 48.5% from 35.3% last year. Orders were $46.7M, 1.4 times sales.
Orders waiting to ship reached $109.3M, and Aehr raised its forecast for the year to June 2027 to $150M, triple last year. A large AI chip maker has decided to buy one wafer machine to test in a production setting; a production order would come later.
What it did to the thesisThe forecast rose instead of falling, the margin recovered and orders beat sales, so nearly all of the year is ordered. The production order we waited for has not come. The view moves from Unattractive to Neutral.
The quarter in detail
Sales growth from the previous quarter, filed figures.
Earnings per share $0.28 against $0.12 expected.
The evidence under this - 5 claims
The 10-Q for the quarter is not yet filed, so the figures are the company's release and call, and bookings and backlog are not audited; the 10-K says most orders can be cancelled or rescheduled with limited penalties (C07).
Bookings and effective backlog are the company's own measures; the filed backlog at the year end was $80.6M and cancellable (C07).
- 2026-11-03editedQ1 fiscal 2027 release: bookings of $46.7M exceeded revenue by over 40% and effective backlog rose to $109.3M after $33.0M was shipped.
The company guided fiscal 2024 to at least $100M in July 2023 and delivered $66.2M (C14).
- 2026-11-03editedQ1 fiscal 2027 release: guide raised from $130M-$150M to $150M, not cut; non-GAAP net income target at least 20% of revenue.
The customer is unnamed and has not ordered; the last guide built on one customer's forecast was cut by a third (C14).
- 2026-11-03editedQ1 fiscal 2027 release and call: the benchmark customer moved from pilot validation to buying a test cell for production-scale evaluation; the production decision is still ahead.
The gap may be filled by orders booked and shipped within the year, as in fiscal 2026's second half (C15).
- 2026-11-03editedFirst-quarter release: $33.0M shipped plus $109.3M effective backlog leaves about $8M to find against the $150M guide, from about $30M-$50M in July.
What management did with the money
Aehr sold new shares as its price rose, raising $97.4M in the year to May 2026, most of it at about $74 a share in April. It has no debt; cash was $105.1M in September after buying long-lead parts, and that cash funds the growth.
Insiders in 2026Q3: 24 purchases and 62 sales, from their Form 4 filings.
The evidence under this - 2 claims
- 2026-11-03editedQ1 fiscal 2027 release and call: cash $105.1M at September 25, down $11.4M on working capital for long-lead parts; still no debt.
The price, and where we disagree
In short. Priced for perfection. The price is about 573% of what we think the business is worth, at an 8% yearly return.
The shares rose sharply over the past year, all of it from investors paying more for each dollar of sales. They hit $145.61 in August, fell by almost half in two weeks with no news, and again between 5 and 22 October, to $55.65. They closed at $51.47 on 2 November, before the results.
The results came after that close. The next test is the second quarter, due in January.
The evidence under this - 4 claims
- 2026-10-23editedre-struck at the 22 October close after a 46.7% fall in 13 sessions, with no company news in between
- 2026-11-03editedRe-struck through the 2 November close of $51.47 for the first-quarter review; the fall from the August close is now 64.7%.
- 2026-10-23editedre-struck at the 22 October close: the year's return and its split are recomputed from the pack's starting close
- 2026-11-03editedFirst quarter reported on November 2 as the calendar suggested; claim rolled to the second quarter.
How we value it
- Method
- Cash the business will produce, with any shortfall raised in new shares
- Required return
- 8%
- Long-run growth
- 4%
- Moat
- An average moat
| Bear | Base | Bull | |
|---|---|---|---|
| Sales growth, years 1 to 3 | 30%, 10.5%, 19.8% | 60%, 21.1%, 39.6% | 75%, 26.4%, 49.5% |
| Normal operating margin | 8.3% | 10.4% | 11.4% |
| Return on new capital after year ten | 8% | 12% | 15% |
| Value a share | $3.44 | $9.20 | $14.73 |
- Price
- $53.57
- Priced on
- 6 Nov
- Price as a share of the base value
- 582%
- Yearly return the price offers on the base case
- 4.9%
- Risk check: valued at 12%, the rate for a business not yet making a profit
- $3.73
Where each figure comes from
| Figure | Source | Where exactly |
|---|---|---|
| Sales, the last twelve months | Filed report | Quarterly report (10-Q) for the period to 25 Sep 2026, filed 6 Nov 2026; the four quarters to that date. |
| Operating margin today | Filed report | Quarterly report (10-Q) for the period to 25 Sep 2026, filed 6 Nov 2026; the four quarters to that date. |
| Tax rate | Our method's rule | The normal rate where no rate is filed to read: 25% for a US company, 21% elsewhere. |
| Sales per dollar of new capital | Filed report | Annual report (10-K) for the period to 29 May 2026, filed 27 Jul 2026: the year's sales over its operating capital. |
| Shares | Filed report | Quarterly report (10-Q) for the period to 25 Sep 2026, filed 6 Nov 2026; the diluted share count. |
| Cash and investments | Filed report | Quarterly report (10-Q) for the period to 25 Sep 2026, filed 6 Nov 2026; the balance sheet on that date. |
| Debt | Filed report | Quarterly report (10-Q) for the period to 25 Sep 2026, filed 6 Nov 2026; the balance sheet on that date. |
| Sales growth, years 1 to 3 | Analysts' forecasts | FMP's consensus for the years to 29 May 2027, 29 May 2028 and 29 May 2029, as it stood when the value was struck on 10 Nov 2026: the average of 1 to 4 analysts' revenue estimates, 60%, 21.1%, 39.6%, each year held to at most 60%. FMP publishes how many analysts, not who they are. |
| Normal operating margin | Analysts' forecasts | FMP's consensus operating margin for the year to 29 May 2029, the average of 2 analysts' estimates, 24.4%, less stock pay of 9.7% of sales and less the 4% the analysts add back on their adjusted basis: 10.8%, which the base case takes as 10.4%. FMP publishes how many analysts, not who they are. |
| Return on new capital after year ten | Our method's rule | Set by our reading of the moat: the 8% rate with none, 12% with an average one, 15% with a strong one; the bear case earns the rate. |
| The bear and bull cases | Our method's rule | Our method's spread: the bear case takes half the growth and a fifth off the margin, the bull a quarter more growth and a tenth more margin. |
| Price | Market price | FMP's closing price on 6 Nov 2026. |
What each case rests on
Bear caseGrowth runs at half the analysts' path, 30%, 10% and 20%, the margin settles a fifth lower at 8.3%, and new capital earns only the 8% rate: the downturn test.
Base caseRevenue grows 60%, 21% and 40% over three years, the analysts' path (C51), held to at most 60% a year, then fades toward 4%, closing 30% of the gap each year; the margin moves to 10.4%, the analysts' year-three figure after stock pay and on the filed basis (4.4% less).
Bull caseGrowth runs a quarter above the analysts' path, 75%, 26% and 50%, the margin reaches 11.4%, and new capital earns 15%.
What moves the base value
| Lower | Higher | |
|---|---|---|
| Growth in years 1 to 3, a quarter lower or higher | $6.89 | $12.02 |
| The normal margin, 15% lower or higher | $7.79 | $10.64 |
| Capital per dollar of growth, a quarter more or less | $8.55 | $9.66 |
| Return on new capital after year ten, at the rate or one step up | $6.83 | $10.18 |
| The rate, a point higher or lower | $6.93 | $13.10 |
| Long-run growth a point lower | $8.07 | - |
Value a share as growth and margin change
| Normal margin ↓ · growth → | 50% | 75% | 100% | 125% | 150% |
|---|---|---|---|---|---|
| 8.3% | $4.42 | $5.51 | $7.32 | $9.51 | $12.05 |
| 9.4% | $4.99 | $6.20 | $8.26 | $10.76 | $13.64 |
| 10.4% | $5.56 | $6.89 | $9.20 | $12.02 | $15.26 |
| 11.4% | $6.14 | $7.59 | $10.16 | $13.30 | $16.91 |
| 12.5% | $6.71 | $8.30 | $11.14 | $14.60 | $18.59 |
Growth is shown as a share of the base case's. Green: the price is at or under 80% of that value. Red: at or over 120%.
How we read the multiple
Aehr is valued at about $1.57B, net of its cash, against $50.0M of sales last year and a forecast of $150M this year.
For the price to work:
- At the raised forecast, $150M, the price is about 10.5 times sales.
- The forecast profit before tax, at least a fifth of sales, would be about $30M.
- That puts the price at about 52 times that profit.
- Analysts expect sales to stay flat the year after, though their figures pre-date the results.
Against its own history. It sits far above its own normal, and the whole rise came from buyers paying more per dollar of sales, while sales per share fell.
The evidence under this - 4 claims
The vendor put company value at $3.26B on an older share count, 63.9 times trailing sales at the October 5 close (S11); the share count here is still July's, and the first-quarter 10-Q will give the current one.
- 2026-10-23editedre-struck at the 22 October close of $55.65, 46.7% below the 5 October close it was struck at
- 2026-11-03editedRe-struck at the 2 November close of $51.47 (from $55.65) with September's cash of $105.1M and the raised $150M guide; the share count is still July's, the 10-Q not yet being filed.
The company guided fiscal 2024 to at least $100M in July 2023 and delivered $66.2M (C14).
- 2026-11-03editedQ1 fiscal 2027 release: guide raised from $130M-$150M to $150M, not cut; non-GAAP net income target at least 20% of revenue.
- 2026-10-23editedre-struck at the 22 October close: the year's return and its split are recomputed from the pack's starting close
Priced against its rivals
Only Trio-Tech International sells the same thing to the same buyers as a large part of what it does. A price comparison needs at least two, so the price is judged against its own history instead.
Also checked and set aside: Cohu (a substitute, not the same product).
Private or foreign rivals that cannot be priced: Suzhou Semight Instruments, Nexustest Instruments, Micro Control Company, KES Systems, Advantest, Pentamaster, AEM Holdings, Chroma ATE, ESPEC.
The bet: what it pays if it works
This is a bet that wafer burn-in becomes standard for AI chips, with a second large chip maker in production. Even then, valued at a rich but not extreme price for each dollar of sales, the company would be worth a little over half of the 5 October price this bet was struck at.
If the AI orders stop once the current orders ship, what is left is the cash and a small car-chip and light-chip business, a small fraction of today's value.
| Revenue in two to three years | FOX-XP systems needed | At the stated multiple |
|---|---|---|
| $140.00M | about 15 at 100% kept | 0.4× |
| $210.00M (the big win) | about 27 at 100% kept | 0.6× |
| $300.00M | about 42 at 100% kept | 0.8× |
To pay 2× (a Fair bet) it would need about $723.56M of revenue (about 112 FOX-XP systems); to pay 5× (a Cheap bet), about $1.81B of revenue (about 293 FOX-XP systems), at the same multiple.
The steps it has to take
- Done Lead AI processor customer in production on wafer-level burn-in
- Done Hyperscaler Sonoma production follow-on order
- In progress Fiscal 2027 revenue of $150M due 2027-06-25
- In progress Benchmark AI processor maker orders for production due 2027-06-30
- Not started A memory maker commits to wafer-level burn-in due 2027-12-31
The detail behind the label
The evidence under this - 7 claims
The customer is unnamed and has not ordered; the last guide built on one customer's forecast was cut by a third (C14).
- 2026-11-03editedQ1 fiscal 2027 release and call: the benchmark customer moved from pilot validation to buying a test cell for production-scale evaluation; the production decision is still ahead.
The customer is unnamed, and EDGAR full-text search finds no filing by onsemi, Intel, TSMC or NVIDIA naming Aehr (S01).
- 2026-11-03editedQ1 fiscal 2027 release and call: cash $105.1M at September 25, down $11.4M on working capital for long-lead parts; still no debt.
The 10-K does not split revenue by AI end market; it gives systems, contactors and services, and wafer against package level (S01).
- 2026-10-23editedre-struck at the 22 October close: the year's return and its split are recomputed from the pack's starting close
The customer is unnamed and no customer filing names Aehr (S01).
- 2026-11-03editedQ1 fiscal 2027 call: more than a dozen Sonoma systems a month, second processor qualified with follow-on orders; all still management's account of an unnamed customer.
Where we disagree with the market
Aehr is the AI burn-in winner: a forecast raised to triple last year, orders up sevenfold and the only wafer machine shown working on AI chips.
This year looks ordered. What the price adds on top rests on customers who have not ordered for production.
In 2023 Aehr forecast at least $100M of sales on one car-chip customer, cut that twice and delivered $66.2M; the shares fell from $54.10 to $9.83. Today's orders are cancellable, the buyers unnamed, and insiders sold into both rallies.
Against us: the forecast rose, orders beat sales, and a second large AI chip maker is buying a machine to test on its production line. If it orders for production, much of our view falls away.
What analysts say, and the evidence
The evidence under this - 6 claims
The vendor put company value at $3.26B on an older share count, 63.9 times trailing sales at the October 5 close (S11); the share count here is still July's, and the first-quarter 10-Q will give the current one.
- 2026-10-23editedre-struck at the 22 October close of $55.65, 46.7% below the 5 October close it was struck at
- 2026-11-03editedRe-struck at the 2 November close of $51.47 (from $55.65) with September's cash of $105.1M and the raised $150M guide; the share count is still July's, the 10-Q not yet being filed.
- 2026-11-03editedQ1 fiscal 2027 release: backlog $100.9M at September 25; the cancellation terms are the 10-K's, and the quarter's 10-Q is not yet filed.
The customer is unnamed and has not ordered; the last guide built on one customer's forecast was cut by a third (C14).
- 2026-11-03editedQ1 fiscal 2027 release and call: the benchmark customer moved from pilot validation to buying a test cell for production-scale evaluation; the production decision is still ahead.
What could go wrong, and how we would know
The risks
- A few buyers Three customers were half of last year's sales and the forecast rests on two unnamed buyers whose orders can be cancelled.
- Rivals for finished chips AEM and others already sell burn-in for finished AI chips, and one large designer chose AEM.
- Margins under pressure Gross margin recovered to 48.5% in the latest quarter from 35.3% last year, but suppliers of power parts raised prices 40%, management says.
- Chinese copies A Chinese rival sells a similar wafer machine and won the first court round; the appeal is pending.
- Orders can slip In fiscal 2024 one customer's slower orders cut the forecast by a third within nine months.
The evidence under this - 8 claims
The customer is unnamed, and EDGAR full-text search finds no filing by onsemi, Intel, TSMC or NVIDIA naming Aehr (S01).
- 2026-11-03editedQ1 fiscal 2027 release: backlog $100.9M at September 25; the cancellation terms are the 10-K's, and the quarter's 10-Q is not yet filed.
Contactors were $14.9M of $50.0M, 30%, in fiscal 2026 (C03), which agrees; the 40% is not in the 10-K.
What we still do not know
- Who the lead AI customer is, and how much more it plans to buy after the $22M order.
- How big the burn-in market is: nobody outside the company measures it.
- Whether the second AI chip maker in trials will order for production, and when.
- Whether any memory maker will commit; management needs one before it builds the product.
The evidence under this - 4 claims
The customer is unnamed, and EDGAR full-text search finds no filing by onsemi, Intel, TSMC or NVIDIA naming Aehr (S01).
SEMI's 2025 figure moved from $11.2B to about $11.7B in seven months, and it counts all test equipment, not burn-in (S18, S19).
The customer is unnamed and has not ordered; the last guide built on one customer's forecast was cut by a third (C14).
- 2026-11-03editedQ1 fiscal 2027 release and call: the benchmark customer moved from pilot validation to buying a test cell for production-scale evaluation; the production decision is still ahead.
No memory maker is named, and management says it will not build the product until one commits.
- 2026-11-03editedQ1 fiscal 2027 call: memory still no committed customer; NAND slower than expected.
What would change our view
- Unattractive→NeutralThe price falls back within 20% of fair value
It needs:
- ○The share price falls to about $11.04, back within 20% of what we think the business is worth.about ≈$8.43 today, 92% below the last close
- Unattractive→AttractiveThe price falls 20% under fair value
It needs:
- ○The share price falls to about $7.36, 80% of what we think the business is worth.about ≈$4.56 today, 96% below the last close
We would also be wrong if
- A memory maker commits to wafer burn-in with an order.
What is coming
- 6 November 2026 Q1 fiscal 2027 results: Whether revenue is ramping toward the $130M to $150M guide, what bookings did after the AI orders, and whether gross margin recovered.
Every dated event ahead
- 6 November 2026 Q1 fiscal 2027 results: Whether revenue is ramping toward the $130M to $150M guide, what bookings did after the AI orders, and whether gross margin recovered.
- 12 February 2027 Q2 fiscal 2027 results: The quarter management called its biggest, when most Sonoma systems ship; a miss there would break the guide.
- 30 June 2027 Semight patent appeal ruling: Whether Aehr can stop its one named rival in China; a loss leaves the silicon carbide design open to copying.
Since we wrote this
- 11 NovThesis reviewUnattractive, high conviction: the view holds even in our best caseConviction re-graded on the new anchors: how robust the view is, not whether anything is still open.
- 9 NovThesis reviewUnattractive: priced at 573% of a value near $9.34Re-valued in three stages at an 8% return, the method now drawn on every thesis: the price sits beyond the 20% margin of safety.
- 3 NovEarningsGuide raised to $150M and price near 10.5 times it; now NeutralRecord $33.0M quarter, $46.7M of bookings and a test-cell purchase by the benchmark customer met route P2: the guide held while the price fell to about 10.5 times it.
- 23 OctPrice movePrice re-struck: 12 times the guide, view heldThe shares fell 47% with no company news; the guide and the orders did not move, so the view waits for the 2 November results.
- 8 OctNewsAehr's lead customer ordered more Sonoma systems; size and timing could not be read. View heldFollow-on Sonoma production orders from the lead hyperscale customer for its next-generation AI processor.
- 6 OctThesis writtenUnattractive, medium convictionWritten three months after the fiscal 2026 print and its AI orders, with the shares back above $100 after a 47% fall and first-quarter results due in early November.
Also checked 5 times with nothing new to act on.
Sources 36
Sources - 36
Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.
- S01primarycompany filing2026-07-27the business description, revenue by category and line, concentration, end-market share, backlog, income statement, cash, the at-the-market sales, share count, deferred tax note, patents, legal proceedings and fiscal-year changebacksC01C02C03C04C05C07C10C11C12C13C14C15C22C23C37C42C45
- S02primarycompany release2026-07-14fourth-quarter revenue and profit, record bookings, effective backlog, the fiscal 2027 guide, the benchmark customer and the photonics winbacksC08C09C19C41
- S03primarycompany release2026-04-07the fiscal 2026 guide and the second-half bookings rangebacksC08C15
- S04primarytranscript2026-07-14Aehr fiscal 2026 fourth-quarter earnings call transcript (FMP)the AI share of revenue, the lead customer's move from system-level test, the yield argument, Sonoma pricing and the $41M order, the benchmark, memory talks, consumables, supplier prices and Nexus Test
I believe that burn-in is by far the fastest growing segment in all of semiconductor test right now.
backsC06C09C16C17C18C19C21C23C26C43C46 - S06primarycompany release2026-07-09the first automated system installed and a follow-on order
This customer took delivery of its first FOX-XP with fully automated WaferPak Aligner production system in fiscal 2026.
backsC20 - S07primarycompany release2026-08-04a nine-blade system at up to 3,500 watts a blade and its ship date
The system is expected to ship during the first half of calendar 2027.
backsC20C49 - S08primarycompany release2026-08-12the order size, what it contains and where it ships
Aehr expects to ship the systems over the next six months for installation at the customer's high-volume manufacturing partner in Taiwan.
backsC16 - S09primarycompany filing2026-10-06every open-market sale with its price, date, filer and Rule 10b5-1 flagbacksC31
- S10primarycompany filing2026-09-09officers and their tenure, beneficial ownership, bonus outcomes and the share-unit targetsbacksC32C33C48
- S11secondaryvendor data2026-10-06AEHR research pack (FMP market tier and FINRA), frozendaily prices, the price-move decomposition, valuation history, analyst estimates and ratings, and short interestbacksC34C35C36C37C38C39
- S13primarycompany filing2022-08-11fiscal 2022 revenue, costs and share count, and the named customers onsemi, Intel and othersbacksC02C05C13
- S14primarycompany release2023-07-13the fiscal 2024 guide of at least $100M and $28M of net incomebacksC14
- S15primarycompany release2024-01-09the guide cut to $75M to $85MbacksC14
- S16primarycompany release2024-04-09the guide cut to more than $65M, made in MarchbacksC14
- S18primaryindustry data2025-12-16test equipment sales for 2025 and the drivers SEMI names
Sales of semiconductor test equipment are projected to surge 48.1% to $11.2 billion in 2025
backsC27 - S19primaryindustry data2026-07-14test equipment sales for 2026 and 2028
After surging 55.3% in 2025, semiconductor test equipment sales are projected to increase 31.0% to $15.3 billion in 2026
backsC27 - S20primarytranscript2026-01-15TSMC fourth-quarter 2025 earnings call transcript (FMP) TSMAI accelerators' share of TSMC revenue and their forecast growth
we raised our forecast for the revenue growth from AI accelerator to approach a mid- to high 50s percent CAGR for the 5 years period from 2024 to 2029.
backsC28 - S21primarytranscript2026-07-16TSMC second-quarter 2026 earnings call transcript (FMP) TSMthat AI accelerator demand ran ahead of the January forecast
We don't give you the number today because it continue to increase, so we don't know how to answer this question. Stronger than what we said before.
backsC28 - S22primaryother2020-06-01a buyer's account of why known-good die matter for chiplet packages
Despite best efforts to produce KGD out of wafer test, there are still a significant number of defects that are being caught at package test
backsC29 - S23primaryindustry data2021-03-01the reverse-bias qualification test and that it is a sample, not a production screen
This sample size is NOT sufficient or intended for process control or PPM evaluation.
backsC30 - S24primaryother2024-03-01wafer-level burn-in in onsemi's silicon carbide screening flow, vendor unnamed
Electrical screening is implemented at multiple levels:
backsC29 - S25primaryother2026-10-06a nine-wafer silicon carbide and gallium nitride burn-in system
Simultaneously perform HTGB and HTRB burn-in tests on 9 wafers
backsC24 - S26primaryother2026-10-06Nexustest WLBI3810 product page Nexustestthe same model numbers as Semight's
WLBI3810 Wafer Level Burn-In System is a high-end burn-in test equipment specifically designed for Silicon Carbide (SiC) and Gallium Nitride (GaN) wafers
backsC24 - S27primaryother2024-07-01a six-to-eight-wafer silicon carbide burn-in system
The Trooper-BI series offers a comprehensive, fully automated solution for wafer-level silicon carbide burn-in
backsC24 - S28primaryother2024-07-09a package-level burn-in rival chosen by an AI chip maker
its burn-in test system has been selected as the Plan-of-Record solution by a major fabless provider of high-performance compute (HPC) and artificial intelligence (AI) semiconductor chips
backsC25 - S29primaryother2026-10-06Advantest selling system-level test and burn-in together
7038 High Parallelism System Level Test (SLT) and Burn-in (BI) Platform
backsC25 - S30primarycompany filing2026-02-19what its system-level testers do, and no burn-in productbacksC26
- S31primarycompany filing2026-09-24burn-in equipment and services, burn-in board growth and AI final test in MalaysiabacksC25
- S33primarynews2001-01-01an early full-wafer burn-in programme at a buyer
The result was that WLBT was as effective as conventional package level burn-in and did not degrade package reliability.
backsC49 - S34primarycompany release2026-07-14the silicon carbide orders and the automaker
Aehr also received a key order directly from one of the largest automotive companies in the world for multiple WaferPaks
backsC44 - S35secondaryvendor data2026-10-22the 22 October 2026 close of $55.65backsC35C36C37
- S36primarycompany filing2026-11-02Q1 fiscal 2027 revenue, margins, bookings, backlog, cash at 25 September 2026 and the raised fiscal 2027 guide of $150M.backsC07C08C09C11C19C36C50
- S37primarytranscript2026-11-02Aehr Test Systems fiscal 2027 first quarter earnings call transcript (FMP), held 2026-11-02The benchmark customer's test-cell purchase and its timetable, Sonoma shipments of more than a dozen systems a month, memory progress, consumables at 41% of revenue, and the unit arithmetic per million processors.
This customer has decided to purchase a full XP wafer level burn in test cell for installation at 1 of its key outsourced semiconductor assembly and test or OSAT partners in Taiwan. Where the system will be evaluated in a high volume production environment using the same device that was successfully tested in last quarter's benchmark.
backsC08C11C18C19C21C50 - S38secondaryvendor data2026-11-02FMP end-of-day price history, AEHR, close of 2 November 2026The 2 November 2026 close of $51.47.backsC35C36
- S39primarycompany filing2026-11-09trailing revenue, operating profit, stock pay, tax, debt, cash and the diluted share countbacksC52
- S40secondaryvendor data2026-11-09the analysts' average revenue and operating profit for the next three fiscal years, and the closebacksC51C52